about
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathyFull-length dystrophin reconstitution with adeno-associated viral vectorsA comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequenceCirculating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy.Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transferTitin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A
P50
Q27301945-458C28D2-3B6D-471B-A8F8-9FC01424A1C7Q33782799-C78993B2-0E89-409C-8D9B-6293D03987C9Q40884119-3AEE30C5-2D24-40EF-A374-F4F0C0F3BE5AQ42209543-43072DDC-B65B-4FE5-93BB-7C9BA1267F8BQ45863762-481A3AA7-CB77-4EB6-8ED4-1E7B9B76558DQ82892069-66D34CC6-700F-4C31-85C9-EF236B6B618FQ91496228-7D9E77AA-18A3-40A8-A098-F124C830BE98
P50
description
researcher ORCID ID = 0000-0003-1014-1950
@en
wetenschapper
@nl
name
William Lostal
@ast
William Lostal
@en
William Lostal
@es
William Lostal
@nl
type
label
William Lostal
@ast
William Lostal
@en
William Lostal
@es
William Lostal
@nl
prefLabel
William Lostal
@ast
William Lostal
@en
William Lostal
@es
William Lostal
@nl
P106
P108
P31
P496
0000-0003-1014-1950